Lipoprotein(a) Particle Core Remodeling and Apolipoprotein C-III Inhibition
Dick C. Chan, Gerald F. Watts · 2026
Read Lipoprotein(a) Particle Core Remodeling and Apolipoprotein C-III Inhibition by Dick C. Chan, Gerald F. Watts (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13601058.txt.
Description
Dick Chan and Gerald Watts review, in a 2026 paper, how a risky blood particle is reshaped in the body and how a new drug class bears on it. The particle, lipoprotein(a), is set largely by genes and raises the risk of heart disease, heart attack, and a stiffened aortic valve. How the body builds and clears it is still only partly known.
The pair trace how the particle trades parts with fat-rich particles in the blood, above all when triglycerides run high. Standard drugs trim those fats and lower a helper protein, apoC-III, by modest amounts. A newer drug, olezarsen, blocks the making of that helper in the liver and cuts triglycerides far more steeply, also lowering pancreatitis risk. The review ties the particle's core changes to that blockade.
Catalog record
| CREATOR | Dick C. Chan, Gerald F. Watts |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 14 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |